FIELD: medicine.
SUBSTANCE: invention relates to medicine and a method of treating hemorrhagic shock or massive blood loss in mammals, which comprises administering tranexamic acid to a mammal in the amount between 0.005 and 0.5 g/kg of the body weight in combination with recombinant full-size SERPING1 or its serpin domain in the amount of 10 to 900 IU/kg of the body weight.
EFFECT: invention provides a significant reduction of mortality caused by hemorrhagic shock or massive blood loss.
6 cl, 8 ex, 10 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION THERAPY FOR TREATING HEMORRHAGIC SHOCK | 2018 |
|
RU2663464C1 |
| METHOD OF TOPICAL TREATMENT OF HYPERFIBRINOLYTIC HEMORRHAGES IN CARDIOSURGERY | 2011 |
|
RU2489974C2 |
| METHOD OF TREATMENT OF UPPER GASTROINTESTINAL BLEEDING | 2016 |
|
RU2657756C2 |
| HYPERFIBRINOLYSIS PREDICTION AND DIAGNOSTIC TECHNIQUE | 2007 |
|
RU2358657C2 |
| METHOD OF PREVENTING BLEEDING CAUSED BY USE OF STREPTOKINASE IN EXPERIMENT | 2014 |
|
RU2552339C1 |
| METHOD FOR PREVENTION OF EARLY POSTPARTUM EXCESSIVE BLOOD LOSS AND COAGULOPATHIC HEMORRHAGE ACCOMPANYING VAGINAL BIRTH | 2012 |
|
RU2484817C1 |
| METHOD FOR TREATMENT OF HEAVY LIVER LESION WITH POSTTRAUMATIC COAGULOPATHY | 2017 |
|
RU2639422C1 |
| HAEMOSTATIC MEDICATION BASED ON SYNTHETIC TRIPEPTIDE PLASMIN INHIBITOR | 2014 |
|
RU2550945C1 |
| METHOD FOR REDUCTION OF FREQUENCY OF INTRAVENTRICULAR HEMORRHAGE IN NEWBORN IN CASE OF EARLY PRETERM DELIVERY, COMPLICATED BY NON-PROGRESSING PLACENTAL ABRUPTION | 2016 |
|
RU2632711C1 |
| GENERAL ANESTHESIA METHOD FOR CARRYING OUT OPERATIVE INTERVENES IN PATIENTS HAVING HEMORRHAGE SHOCK | 1998 |
|
RU2135170C1 |
